A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)

Clinical trial NCT05100303 · UNKNOWN

Trial details

NCT number: NCT05100303
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)

Start date: 2021-12-01
Primary completion: 2022-11-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.